Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5201552
Max Phase: Preclinical
Molecular Formula: C13H17NO2
Molecular Weight: 219.28
Associated Items:
ID: ALA5201552
Max Phase: Preclinical
Molecular Formula: C13H17NO2
Molecular Weight: 219.28
Associated Items:
Canonical SMILES: O=Cc1ccc(O)c(CN2CCCCC2)c1
Standard InChI: InChI=1S/C13H17NO2/c15-10-11-4-5-13(16)12(8-11)9-14-6-2-1-3-7-14/h4-5,8,10,16H,1-3,6-7,9H2
Standard InChI Key: ANOQAWNFSFYKLF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 219.28 | Molecular Weight (Monoisotopic): 219.1259 | AlogP: 2.19 | #Rotatable Bonds: 3 |
Polar Surface Area: 40.54 | Molecular Species: ZWITTERION | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 6.14 | CX Basic pKa: 8.74 | CX LogP: 0.80 | CX LogD: 0.83 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.79 | Np Likeness Score: -0.42 |
1. Pape VFS, Palkó R, Tóth S, Szabó MJ, Sessler J, Dormán G, Enyedy ÉA, Soós T, Szatmári I, Szakács G.. (2022) Structure-Activity Relationships of 8-Hydroxyquinoline-Derived Mannich Bases with Tertiary Amines Targeting Multidrug-Resistant Cancer., 65 (11.0): [PMID:35613553] [10.1021/acs.jmedchem.2c00076] |
Source(1):